Cost savings in quality improvement project to prevent venous thromboembolism

Journal of Vascular Nursing

Volumn 25, Issue 4, 2007, Pages 70-74

  Gilpin, Victoria L ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST CONTROL; ECONOMICS; EDUCATION; EVALUATION; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; NURSE PRACTITIONER; NURSING; NURSING ASSESSMENT; NURSING EDUCATION; NURSING EVALUATION RESEARCH; NURSING STAFF; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PRACTICE GUIDELINE; RISK FACTOR; SAFETY; TEACHING HOSPITAL; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOEMBOLISM;

COST SAVINGS; EDUCATION, NURSING, CONTINUING; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HOSPITALS, TEACHING; HUMANS; MISSOURI; NURSE PRACTITIONERS; NURSING ASSESSMENT; NURSING AUDIT; NURSING EVALUATION RESEARCH; NURSING STAFF, HOSPITAL; ORGANIZATIONAL INNOVATION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT CARE TEAM; PRACTICE GUIDELINES AS TOPIC; PROGRAM EVALUATION; RISK FACTORS; SAFETY MANAGEMENT; TOTAL QUALITY MANAGEMENT; VENOUS THROMBOEMBOLISM;

EID: 36148965871     PISSN: 10620303     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvn.2007.07.015     Document Type: Article

References (12)

1. Coalition to Prevent Deep Vein Thrombosis. www.PreventDVT.Org Accessed March 26, 2007
2. Deep Vein Thrombosis: Advancing awareness to protect patient lives. White paper, page 3. Public Health Leadership Conference Washington, D.C., February 26, 2003. American Public Health Association.
3. White T.J. The use of pharmacoeconomics in formulary development: can this improve the way deep vein thrombosis is treated?. Am J Manag Care 7 (2001) S545-S550
4. Leape L., Berwick D., and Bates D. What practices will most improve patient safety?. JAMA 288 (2002) 501-507
5. Medicare Quality Improvement Community. SCIP process and outcome measures. http://quality indicators.ahrq.gov Available at: Accessed March 19, 2007.
6. White T.J. The use of pharmoeconomics in formulary development: can this improve the way deep vein thrombosis is treated?. Am J Manag Care 7 (2001) S545-S550
7. Maynard G., and Halasyamani L. Venous thromboembolism prophylaxis for hospitalized patients: an implementation guide and model for improvement. Hospitalist 8 (2004) 27-29
8. Clagett G.P., Anderson Jr. F.A., Levine M.N., Salzman E.W., and Wheeler H.B. Prevention of venous thromboembolism. Chest 102 (1992) S391-S407
9. Clagett G.P., Anderson Jr. F.A., Geerts W., et al. Prevention of venous thromboembolism. Chest 114 (1998) 531S-60
10. Geerts W.H., Heit J.A., Clagett G.P., et al. Prevention of venous thromboembolism. Chest 119 (2001) 132S-75
11. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolysis Therapy. Chest 126 (2004) 338S-400
12. Caprini J.A., Arcelus J.I., and Reyna J.J. Effective risk stratification of surgical and non surgical patients for venous thromboembolic disease. Semin Hematol 38 (2001) 12-19